Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 12p12 1 Microdeletion Syndrome C4755260
Clinical comparison between 2p13 2 Microdeletion Syndrome and 12p12 1 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
12p12 1 Microdeletion Syndrome C4755260
A rare chromosomal condition involving a small missing piece of chromosome 12. Features vary but may include developmental delays and congenital differences. Care involves monitoring and supportive interventions.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
12p12 1 Microdeletion Syndrome C4755260
0-null
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
12p12 1 Microdeletion Syndrome C4755260
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
12p12 1 Microdeletion Syndrome C4755260
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
12p12 1 Microdeletion Syndrome C4755260
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
12p12 1 Microdeletion Syndrome C4755260
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
12p12 1 Microdeletion Syndrome C4755260
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 12p12-1-microdeletion-syndrome-C4755260 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 12p12 1 Microdeletion Syndrome C4755260 | Discriminating power |
|---|---|---|---|
| Chromosome region | Small missing segment reported at 2p13.2; affected genes vary. | Small missing segment reported at 12p12.1; affected genes vary. | High |
| Reported severity | Source label is severe, but individual manifestations are not fixed. | Source label is moderate, but individual manifestations are not fixed. | Moderate |
| Clinical features | No definitive symptom pattern is established from the supplied description. | Developmental delay and congenital differences may occur, but are not universal. | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
A genetic report localizes a deletion to 2p13.2.
The chromosome band, not shared symptoms, identifies this finding.
High
Counseling concerns the genes within a confirmed 2p13.2 deletion.
Gene content and breakpoints require locus-specific specialist review.
Moderate
A severe congenital presentation lacks a mapped deletion.
Severity alone does not establish this syndrome.
Low
Choose 12p12 1 Microdeletion Syndrome C4755260 when
A genetic report localizes a deletion to 12p12.1.
The chromosome band distinguishes this finding from 2p13.2 deletion.
High
Developmental delay occurs with a confirmed 12p12.1 deletion.
The finding may be relevant, but causality still needs clinical correlation.
Moderate
Moderate symptoms occur without chromosomal mapping.
Symptom severity cannot reliably select this diagnosis.
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 12p12 1 Microdeletion Syndrome C4755260 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a copy-number loss at 2p13.2. | May show a copy-number loss at 12p12.1. | Band, size, and gene content require laboratory and clinician interpretation. |
| Standard karyotype | May be normal if the deletion is below its resolution. | May also be normal when the deletion is small. | A normal karyotype does not exclude either microdeletion. |
| Parental genetic studies | May clarify inheritance, but result is not predictable here. | May clarify inheritance, but result is not predictable here. | Inheritance and recurrence risk must be individualized. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the source severity label is severe, but course varies.
- Factors
- Deletion size, genes, associated findings, and available support may influence course.
12p12 1 Microdeletion Syndrome C4755260
- Outcome
- Long-term outcome is not established; the source severity label is moderate, but course varies.
- Factors
- Developmental needs, congenital findings, inheritance, and interventions may influence course.
Time frame: Both are lifelong congenital conditions; exact trajectories are not established.
Prognosis requires clinician interpretation of the full genetic report and clinical evaluation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental differences | Possible, but no specific pattern is established here. May include developmental delay; extent varies. Assessment should guide support rather than assume a fixed course. |
| Congenital differences | Possible depending on involved genes; details are not supplied. Congenital differences may occur, with variable type and severity. Organ-specific evaluation depends on clinical findings. |
| Family implications | Recurrence risk cannot be stated without parental results. Recurrence risk likewise depends on inheritance testing. Genetic counseling is appropriate for both findings. |
Patient education highlights
- HighMeaning of the result
This is a chromosomal finding, not a complete prediction of health or ability.
- HighIndividual care
Features vary; clinicians tailor monitoring and supportive care to the person.
- MediumTransmission
Neither condition is contagious; inheritance questions require genetic counseling.